The small number of patients with CKD might be insufficient to determine the reliability and generalizability of serum HE4 and NT-proBNP as biomarkers of A on C. Finally, although this study aimed to identify the potential biomarkers for predicting A on C, the underlying mechanism of these predictors in A on C remains unclear, which requires further investigation. This evidence concerns the gene WFDC2 and chronic kidney disease.